Alembic Pharma has received EIR report from USFDA
Alembic Pharmaceuticals has got the Establishment Inspection Report from the USFDA for its formulation facility located at Panelav in Gujarat. Alembic Pharmaceuticals has said in...
Tag : USFDA
Cadila Healthcare has received EIR for Ahmedabad plant from USFDA
Cadila Healthcare has received an Establishment Inspection Report (EIR) from the US health regulator for its manufacturing plant in Ahmedabad. Cadila Healthcare Ltd has said...
USFDA has issued warning letter to Unimark Remedies
The US Food and Drug Administration (USFDA) has warned Unimark Remedies on violation of good manufacturing practices at its two plants in Gujarat. It added...
Cadila has received EIR from USFDA for Changodar facility
Cadila Healthcare has got the Establishment Inspection Report (EIR) for its Changodar manufacturing plant that is located near Ahmedabad, from the US health regulator after...
Alembic Pharma has received tentative approval from USFDA for Febuxostat
The US health regulator has provided its tentative approval to Alembic Pharmaceuticals for Febuxostat tablets that are used in the treatment of hyperuricemia in patients...
EIC, USFDA signs agreement to share information on import alerts
An agreement has been signed by the Export Inspection Council of India and the US health regulator for facilitating the sharing of information relating to...
Strides Shasun has received EIR report from USFDA
An Establishment Inspection Report (EIR) has been received by the drug firm Strides Shasun from the US health regulator on closure of inspection of its...
Strides receives tentative approval from USFDA for Roflumilast tablets
The US health regulator has given its tentative approval to Strides Shasun for Roflumilast tablets that are used in the treatment of inflammatory conditions of...
Lupin has got EIR report from USFDA on inspection closure
Lupin, the pharma major has got an establishment inspection report (EIR) from the USFDA on closure of inspection of its Mandideep and Aurangabad facilities. Lupin...
Glenmark has received 3 observations from USFDA for Indore plant
Three observations have been received by Glenmark Pharmaceuticals from the US health regulator for its Pithampur, Indore plant. The company, however said that it has...